Posted in | News | Gold | Mining Business

Chilean Metals Completes Purchase of Three Mining Concessions near Candelaria Mine

Chilean Metals Inc. has completed the previously announced purchase of three mining concessions totalling 600 hectares (1,483 acres) near the Candelaria mine in Chile's Third Region from private Chilean owners. Under the terms of the agreement, CMX paid the vendors $50,000 USD in cash and issued 600,000 shares.

Chilean Metals had previously completed the acquisition of nine mining concessions totalling 724 hectares (1,789 acres) from Compañia Minera Casale, a company jointly owned by Chilean subsidiaries of Barrick Gold Corp. and Kinross Gold Corporation, respectively, for the sum of US$50,000.

CMX CEO Terry Lynch commented "CMX's experienced geological team had identified Zulema as a high potential exploration asset. After two years and considerable human and financial capital Chilean Metals is very pleased to announce its assembly of 4,300 hectares (10,626 acres) on its Zulema property in Chile's Third Region. All concessions are held 100% by the Chilean subsidiary of Chilean Metals, with no underlying third party royalty or net profits interest." The project is located 30 kilometers from the giant Cu-Au Candelaria mine of Lundin Mining Corporation and in a very similar geological environment. An 80% interest in the above referenced Candelaria mine was recently acquired by its current owners from Freeport McMoran for approximately US $1.8 billion dollars. Candelaria produced 370 million pounds of copper and 87,000 ounces of gold last year."

"The Zulema property is very well located in terms of mining infrastructure: it is road accessible, at low elevation, 30 kilometers from the mining centre of Copiapo and 15 kilometers from the Pan American Highway as well as Chile's main power grid. From a cost perspective, we believe it to be an ideal project to explore, develop and mine. Unlike projects further east at higher elevation, work at Zulema can be conducted year-round. The Company's plans this calendar year include drilling already identified targets at Zulema in late Q2 or early Q3 subject only to financing" continued Mr. Lynch. More details on Zulema can be found on CMX's website at

http://chileanmetals.com/projects/zulema/

To finance the closing of the subject property acquisition, Chilean Metals completed a $190,000 CAD debenture financing. The terms were as follows: 14% interest annually in arrears at loan repayment, secured by the shares of our Chilean subsidiary that contains a 3% royalty CMX retained through sale of its Copaquire asset to a subsidiary of Teck Resources Inc. More details on the royalty can be found on CMX's website at

http://chileanmetals.com/projects/copaquire-royalty/

The Company can, should it so choose, place a combined debenture totalling $1,000,000 USD secured in this fashion. The loan is due Oct 31, 2016, or upon sale of all or part of the Teck Royalty. The loan can be prepaid up until July 1 2015 by the Company paying a 20% penalty. Total fees of 14% were paid on this transaction. In addition, if the loan is outstanding after July 1, 2015, CMX will provide the debenture holder 1,900,000 warrants entitling holder to exchange one warrant and $0.05 to acquire one share up to Oct 31 2016. The transaction is subject to final approval from the TSX Venture Exchange.

"The Zulema project was very well received at PDAC and the Company has six outstanding NDA's, all from companies that are well capitalized. Zulema is an excellent exploration project and even under current market conditions we are confident of either joint venturing with one of these groups or raising the additional capital ourselves. We look forward to drilling at Zulema to show the market its true potential. " added CMX CEO Terry Lynch.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.